Literature DB >> 11131990

Phenotypic change of human cultured meningioma cells.

R Pallini1, P Casalbore, D Mercanti, N Maggiano, L M Larocca.   

Abstract

One objection to using cell cultures for studying the proliferation of tumors is the potential for phenotypic changes that may occur in vitro. Here, we compared the antigen pattern expression of cultured meningioma cells with that of the primary tumor. Cell cultures established from 9 intracranial meningiomas and deparaffinized sections of the resected tumors were analyzed for immunophenotyping with the following antibodies: vimentin, cytokeratin, epithelial membrane antigen, S-100, neuron-specific enolase, synaptophisin, factor VIII-related antigen, CD4, CD31, CD34, CD45RB, CD68-PGM1, CD68-KP, and myeloid/histiocyte antigen (MAC387). Overall, the cultured meningioma cells retained the main feature of the primary tumor, being positive both for mesenchymal antigens and for epithelial antigens. Interestingly, the cultured meningioma cells abundantly expressed the CD68 antigens at early passage. The CD68 antigens, which are normally found on hematopoietic cells like macrophages and monocytes, were not detectable on meningioma cells in situ. Our results show that phenotypic changes on human meningioma cells may occur in vitro. This phenomenon suggests caution when transposing the in vitro results to the in vivo condition.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11131990     DOI: 10.1023/a:1006436903976

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  25 in total

1.  Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia.

Authors:  S C Lee; W Liu; C F Brosnan; D W Dickson
Journal:  Lab Invest       Date:  1992-10       Impact factor: 5.662

2.  Distribution of the CD68 macrophage/myeloid associated antigen.

Authors:  K A Pulford; A Sipos; J L Cordell; W P Stross; D Y Mason
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

3.  Meningiomas. An immunohistochemical study of 50 cases.

Authors:  J M Meis; N G Ordóñez; J M Bruner
Journal:  Arch Pathol Lab Med       Date:  1986-10       Impact factor: 5.534

4.  Presidential address: the histopathology of meningiomas. A reflection of origins and expected behavior?

Authors:  J J Kepes
Journal:  J Neuropathol Exp Neurol       Date:  1986-03       Impact factor: 3.685

5.  Expression of epithelial and extracellular matrix protein markers in meningiomas.

Authors:  H K NG; A T Wong
Journal:  Histopathology       Date:  1993-02       Impact factor: 5.087

6.  Thrombin and TGF-beta promote human leptomeningeal cell proliferation in vitro.

Authors:  O Motohashi; M Suzuki; N Yanai; K Umezawa; N Shida; T Yoshimoto
Journal:  Neurosci Lett       Date:  1995-05-05       Impact factor: 3.046

7.  The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells.

Authors:  L M Larocca; D Capello; A Rinelli; S Nori; A Antinori; A Gloghini; A Cingolani; A Migliazza; G Saglio; S Cammilleri-Broet; M Raphael; A Carbone; G Gaidano
Journal:  Blood       Date:  1998-08-01       Impact factor: 22.113

8.  Secretion of interleukin-6 by human meningioma cells: possible autocrine inhibitory regulation of neoplastic cell growth.

Authors:  T Todo; E F Adams; B Rafferty; R Fahlbusch; T Dingermann; H Werner
Journal:  J Neurosurg       Date:  1994-09       Impact factor: 5.115

9.  Interleukin-6 (IL-6) production and cell growth of cultured human ameningiomas:-interactions with interleukin-1 beta (IL-1 beta) and interleukin-4 (IL-4) in vitro.

Authors:  E Boyle-Walsh; I A Hashim; V Speirs; W D Fraser; M C White
Journal:  Neurosci Lett       Date:  1994-03-28       Impact factor: 3.046

10.  In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists.

Authors:  R L Jensen; T C Origitano; Y S Lee; M Weber; R D Wurster
Journal:  Neurosurgery       Date:  1995-02       Impact factor: 4.654

View more
  6 in total

Review 1.  Intracranial benign fibrous histiocytomas: a case report and review.

Authors:  Jennifer A Moliterno; Shreya Sood; Eduardo Zambrano; Jung H Kim; Joseph M Piepmeier; Joachim M Baehring
Journal:  J Neurooncol       Date:  2008-11-22       Impact factor: 4.130

2.  CD133-positive cells might be responsible for efficient proliferation of human meningioma cells.

Authors:  Hailiang Tang; Ye Gong; Ying Mao; Qing Xie; Mingzhe Zheng; Daijun Wang; Hongda Zhu; Xuanchun Wang; Hong Chen; Xiancheng Chen; Liangfu Zhou
Journal:  Int J Mol Sci       Date:  2012-05-23       Impact factor: 6.208

Review 3.  Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells.

Authors:  Mohammed I Khan; Anna M Czarnecka; Igor Helbrecht; Ewa Bartnik; Fei Lian; Cezary Szczylik
Journal:  Stem Cell Res Ther       Date:  2015-09-16       Impact factor: 6.832

4.  Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines.

Authors:  Ishaq Khan; Saleh Baeesa; Mohammed Bangash; Hans-Juergen Schulten; Fahad Alghamdi; Hanadi Qashqari; Nawal Madkhali; Angel Carracedo; Mohamad Saka; Awatif Jamal; Jaudah Al-Maghrabi; Mohammed AlQahtani; Saleh Al-Karim; Ghazi Damanhouri; Kulvinder Saini; Adeel Chaudhary; Adel Abuzenadah; Deema Hussein
Journal:  Cancer Cell Int       Date:  2017-07-21       Impact factor: 5.722

Review 5.  Bone Invasive Meningioma: Recent Advances and Therapeutic Perspectives.

Authors:  Hajime Takase; Tetsuya Yamamoto
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

Review 6.  Renal Cancer Stem Cells: Characterization and Targeted Therapies.

Authors:  Anna Julie Peired; Alessandro Sisti; Paola Romagnani
Journal:  Stem Cells Int       Date:  2016-05-15       Impact factor: 5.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.